Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Clinical Research and Public HealthIn-Press PreviewCell biologyOncology Open Access | 10.1172/JCI203289

Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types

Zi-Wei Huang,1 Zi-Han Wang,1 Yi Liu,1 Jia-Yi Shen,1 Yan-Ling Wu,2 Zi-An Fang,1 Dong-Hong Wu,1 Yi-Zhe Cheng,1 Jing-Jing Zhang,1 Xiong Zou,1 Jun Ma,1 Jiawei Lv,1 Shuang Wang,1 and Yu-Pei Chen1

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Huang, Z. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Wang, Z. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Liu, Y. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Shen, J. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Wu, Y. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Fang, Z. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Wu, D. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Cheng, Y. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Zhang, J. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Zou, X. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Ma, J. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Lv, J. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Wang, S. in: PubMed | Google Scholar

1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Find articles by Chen, Y. in: PubMed | Google Scholar

Published November 17, 2026 - More info

J Clin Invest. https://doi.org/10.1172/JCI203289.
Copyright © 2026, Huang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 17, 2026 - Version history
View PDF
Abstract

BACKGROUND. Molecular subtyping may offer a promising path toward a unified framework for precision oncology. We sought to characterize the patterns of programmed cell death (PCD), a pivotal cellular process shaping both intrinsic tumor malignancy and the tumor microenvironment, to better understand tumor heterogeneity.

METHODS. We performed integrative multi-cohort transcriptomic analyses encompassing four canonical PCD modes across multiple cancer types. We identified PCD subtypes using nonnegative matrix factorization (NMF), characterized their molecular features and clinical relevance, and developed a streamlined 20-gene classifier to facilitate subtype assignment.

RESULTS. We identified five conserved PCD subtypes with distinct genomic alterations, cellular stresses, malignant traits, prognostic outcomes, and immune landscapes. In the immunotherapy setting, PCD subtypes were associated with distinct outcomes across multiple cancer types, with the pyroptosis-dominant (PCD-P) subtype showing the most favorable outcomes. The 20-gene classifier showed good discriminatory performance across independent cohorts. Finally, we proposed candidate subtype-specific therapeutic strategies.

CONCLUSION. This study establishes a comprehensive framework for characterizing PCD patterns in cancer, laying the groundwork for biomarker discovery and rational therapeutic design that warrant future evaluation of efficacy and toxicity.

FUNDING. National Key R&D Program of China; National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities, Sun Yat-sen University; HE Science Foundation; Young Talents Program of Sun Yat-sen University Cancer Center; Academician Workstation of Jun Ma; Specific Research Fund of the Innovation Platform for Academicians of Hainan Province; Shenzhen Medical Research Fund; Guangdong Basic and Applied Basic Research Foundation.

Graphical Abstract
graphical abstract
Supplemental material

View

View Supplemental Table 1

View Supplemental Table 2

View Supplemental Table 3

View Supplemental Table 4

View Supplemental Table 5

View Supplemental Table 6

View Supplemental Table 7

Version history
  • Version 1 (November 17, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts